NASDAQ:OPGN
OpGen, Inc. Stock News
$0.535
+0.0201 (+3.90%)
At Close: Apr 29, 2024
OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2021
07:30am, Monday, 04'th Oct 2021
ROCKVILLE, Md., Oct. 04, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat
OPGN Stock: Why It Noticeably Increased Today
06:10am, Monday, 04'th Oct 2021
The stock price of OpGen Inc (NASDAQ: OPGN) increased by over 15% pre-market today. This is why it happened.
OpGen Initiates Clinical Trial for Unyvero Urinary Tract Infection Panel
07:30am, Thursday, 30'th Sep 2021
ROCKVILLE, Md., Sept. 30, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat
Best Penny Stocks To Buy Now? Watch These 5 Today
08:21am, Wednesday, 22'nd Sep 2021
Are These On Your Penny Stocks Watch List Today? The post Best Penny Stocks To Buy Now?
- Unyvero reduced the use of inappropriate antibiotic therapy by 45.1%
4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507%
12:21pm, Tuesday, 14'th Sep 2021
Biotech Penny Stocks Surge As Sector Reverses Course The post 4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507% appeared first on Penny Stocks to Buy, Picks, News and Information
OpGen, Inc. (OPGN) CEO Oliver Schacht on Q2 2021 Results - Earnings Call Transcript
10:45pm, Thursday, 12'th Aug 2021
OpGen, Inc. (OPGN) CEO Oliver Schacht on Q2 2021 Results - Earnings Call Transcript
OpGen, Inc. (OPGN) Reports Q2 Loss, Misses Revenue Estimates
09:35pm, Thursday, 12'th Aug 2021
OpGen, Inc. (OPGN) delivered earnings and revenue surprises of 0.00% and -22.67%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
OpGen Reports Second Quarter 2021 Financial Results and Provides Business Update
04:15pm, Thursday, 12'th Aug 2021
Conference call to be held at 4:30 p.m. Eastern Daylight Savings Time today
OpGen, Inc. (OPGN) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
04:48pm, Wednesday, 04'th Aug 2021
OpGen, Inc. (OPGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OpGen Announces the Cancellation of Adjourned Portion of Annual Meeting
04:30pm, Wednesday, 04'th Aug 2021
ROCKVILLE, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and informati
OpGen to Provide Business Update and Financial Results for the Second Quarter 2021 on August 12th at 4:30 p.m. Eastern Time
07:30am, Wednesday, 04'th Aug 2021
ROCKVILLE, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its second qu
OpGen Achieves Key Development Milestone in Unyvero A30 RQ Platform Program
07:30am, Tuesday, 03'rd Aug 2021
- OpGen subsidiary Curetis and its instrument development partner have completed assembly of 10 final pre-series release A30 RQ analyzers
OpGen Announces Partial Adjournment of Annual Meeting
04:30pm, Wednesday, 07'th Jul 2021
ROCKVILLE, Md., July 07, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and informati
OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AMR Gene Panel for Isolates Data Presented at World Microbe Forum
07:30am, Wednesday, 30'th Jun 2021
- Unyvero studies demonstrated potential for therapy adjustment in 42% to 53% of patients with results available 1 to 2 days faster
